Intec Pharma is a clinical-stage biopharmaceutical company focused on developing drugs based on its proprietary Accordion Pill® (AP) platform technology. The Company’s Accordion Pill® is an oral drug delivery system that is designed to improve the efficacy and safety of existing drugs and drugs in development by utilizing an efficient gastric retention and specific release mechanism.
The AP is a unique delivery platform based on folded multilayer films. AP provides a better treatment through improving pharmacokinetics of drugs with narrow absorption windows or poor solubility. Furthermore, AP allows multiple drug release profiles in a single capsule and can provide fixed-dose combinations. Importantly, the AP safety and efficacy have been tested in more than 30 clinical studies, with more than tens of thousands of administrations. Intec holds several granted patent families that cover the AP technology.